ADR Biomedical Holdings Inc.

¥774.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:3750Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 13.45%
Div yield —
ROE (267.63%)
Biotechnology
Beta (5Y) 0.17
PE TTM —
TSR TTM (6.63%)
Mkt cap ¥6.910B
ROIC (1806.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥871
12.58%
12.97%
Buy 12|10|12|2|2
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
6.84
7.50
7.88
8.29
6.46%
15.65%
17.18%
28.88%
Revenue¥M
314.2
324.0
320.9
323.6
8.41%
14.57%
11.26%
7.87%
Peers (US$43.88M)
Cap (US$)
PE
45.38M
—
44.18M
—
43.25M
20.79x
Capital
TTM
5Y
10Y
Leveragex
0.131
0.635
0.495
EBIT/Intx
0.268
0.402
0.416
Own earn%
(12.96)
2.54
0.67
Sh yield%
40.63
18.09
19.88
Owners
Insiders/Inst%
1.76
43.53
Short interest%
5.68
SBC / revenue%
0.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
7–13
$1 testx
—
Incr. ROIC%
1